Genetic and epigenetic regulation of gene expression in fetal and adult human livers

BMC Genomics

Volumn 15, Issue 1, 2014, Pages

  Bonder, Marc Jan ^a   Kasela, Silva ^b,c   Kals, Mart ^b,c   Tamm, Riin ^b,c   Lokk, Kaie ^c   Barragan, Isabel ^d   Buurman, Wim A ^e   Deelen, Patrick ^a   Greve, Jan Willem ^f   Ivanov, Maxim ^d   Rensen, Sander S ^e   Van Vliet Ostaptchouk, Jana V ^a   Wolfs, Marcel G ^a   Fu, Jingyuan ^a   Hofker, Marten H ^a   Wijmenga, Cisca ^a   Zhernakova, Alexandra ^a   Ingelman Sundberg, Magnus ^d   Franke, Lude ^a   Milani, Lili ^b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF TARTU   (Estonia)

^c UNIVERSITY OF TARTU   (Estonia)

^d KAROLINSKA INSTITUTE   (Sweden)

^e MAASTRICHT UNIVERSITY   (Netherlands)

^f Sittard Geleen Heerlen   (Netherlands)

Author keywords

eQTL; eQTM; Gene expression; HumanMethylation450; Liver; meQTL; Methylation

Indexed keywords

ADULT; ANTIBODY SPECIFICITY; DNA METHYLATION; EMBRYOLOGY; EPIGENETICS; FETUS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; LIVER; METABOLISM; QUANTITATIVE TRAIT LOCUS; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; DNA METHYLATION; EPIGENESIS, GENETIC; EPIGENOMICS; FETUS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; LIVER; ORGAN SPECIFICITY; POLYMORPHISM, SINGLE NUCLEOTIDE; QUANTITATIVE TRAIT LOCI;

EID: 85027919555     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-15-860     Document Type: Article

References (48)

1. Sabatti C, Service SK, Hartikainen A-L, Pouta A, Ripatti S, Brodsky J, Jones CG, Zaitlen NA, Varilo T, Kaakinen M, Sovio U, Ruokonen A, Laitinen J, Jakkula E, Coin L, Hoggart C, Collins A, Turunen H, Gabriel S, Elliot P, McCarthy MI, Daly MJ, Järvelin M-R, Freimer NB, Peltonen L: Genome-wide association analysis of metabolic traits in a birth cohort from a founder population. Nat Genet 2009, 41:35-46.
2. Qi L, Cornelis MC, Kraft P, Stanya KJ, Linda Kao WH, Pankow JS, Dupuis J, Florez JC, Fox CS, Paré G, Sun Q, Girman CJ, Laurie CC, Mirel DB, Manolio TA, Chasman DI, Boerwinkle E, Ridker PM, Hunter DJ, Meigs JB, Lee C-H, Hu FB, van Dam RM: Genetic variants at 2q24 are associated with susceptibility to type 2 diabetes. Hum Mol Genet 2010, 19:2706-2715.
3. Voight BF, Scott LJ, Steinthorsdottir V, Morris AP, Dina C, Welch RP, Zeggini E, Huth C, Aulchenko YS, Thorleifsson G, McCulloch LJ, Ferreira T, Grallert H, Amin N, Wu G, Willer CJ, Raychaudhuri S, McCarroll SA, Langenberg C, Hofmann OM, Dupuis J, Qi L, Segrè AV, van Hoek M, Navarro P, Ardlie K, Balkau B, Benediktsson R, Bennett AJ, Blagieva R: Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet 2010, 42:579-589.
4. Suhre K, Shin S-Y, Petersen A-K, Mohney RP, Meredith D, Wägele B, Altmaier E, Deloukas P, Erdmann J, Grundberg E, Hammond CJ, de Angelis MH, Kastenmüller G, Köttgen A, Kronenberg F, Mangino M, Meisinger C, Meitinger T, Mewes H-W, Milburn MV, Prehn C, Raffler J, Ried JS, Römisch-Margl W, Samani NJ, Small KS, Wichmann H-E, Zhai G, Illig T, Spector TD: Human metabolic individuality in biomedical and pharmaceutical research. Nature 2011, 477:54-60.
5. Adams LA, White SW, Marsh JA, Lye SJ, Connor KL, Maganga R, Ayonrinde OT, Olynyk JK, Mori TA, Beilin LJ, Palmer LJ, Hamdorf JM, Pennell CE: Association between liver-specific gene polymorphisms and their expression levels with nonalcoholic fatty liver disease. Hepatology 2013, 57:590-600.
6. Ellinghaus D, Folseraas T, Holm K, Ellinghaus E, Melum E, Balschun T, Laerdahl JK, Shiryaev A, Gotthardt DN, Weismüller TJ, Schramm C, Wittig M, Bergquist A, Björnsson E, Marschall H-U, Vatn M, Teufel A, Rust C, Gieger C, Wichmann H-E, Runz H, Sterneck M, Rupp C, Braun F, Weersma RK, Wijmenga C, Ponsioen CY, Mathew CG, Rutgeerts P, Vermeire S: Genome-wide association analysis in primary sclerosing cholangitis and ulcerative colitis identifies risk loci at GPR35 and TCF4. Hepatology 2013, 58:1074-1083.
7. Schadt EE, Molony C, Chudin E, Hao K, Yang X, Lum PY, Kasarskis A, Zhang B, Wang S, Suver C, Zhu J, Millstein J, Sieberts S, Lamb J, GuhaThakurta D, Derry J, Storey JD, Avila-Campillo I, Kruger MJ, Johnson JM, Rohl CA, van Nas A, Mehrabian M, Drake TA, Lusis AJ, Smith RC, Guengerich FP, Strom SC, Schuetz E, Rushmore TH: Mapping the genetic architecture of gene expression in human liver. PLoS Biol 2008, 6:e107.
8. Greenawalt DM, Dobrin R, Chudin E, Hatoum IJ, Suver C, Beaulaurier J, Zhang B, Castro V, Zhu J, Sieberts SK, Wang S, Molony C, Heymsfield SB, Kemp DM, Reitman ML, Lum PY, Schadt EE, Kaplan LM: A survey of the genetics of stomach, liver, and adipose gene expression from a morbidly obese cohort. Genome Res 2011, 21:1008-1016.
9. Innocenti F, Cooper GM, Stanaway IB, Gamazon ER, Smith JD, Mirkov S, Ramirez J, Liu W, Lin YS, Moloney C, Aldred SF, Trinklein ND, Schuetz E, Nickerson DA, Thummel KE, Rieder MJ, Rettie AE, Ratain MJ, Cox NJ, Brown CD: Identification, replication, and functional fine-mapping of expression quantitative trait loci in primary human liver tissue. PLoS Genet 2011, 7:e1002078.
10. Schröder A, Klein K, Winter S, Schwab M, Bonin M, Zell A, Zanger UM: Genomics of ADME gene expression: Mapping expression quantitative trait loci relevant for absorption, distribution, metabolism and excretion of drugs in human liver. Pharmacogenomics J 2013, 13:12-20.
11. Fu J, Wolfs MGM, Deelen P, Westra H-J, Fehrmann RSN, Te Meerman GJ, Buurman WA, Rensen SS, Groen HJ, Weersma RK, van den Berg LH, Veldink J, Ophoff RA, Snieder H, van Heel D, Jansen RC, Hofker MH, Wijmenga C, Franke L: Unraveling the regulatory mechanisms underlying tissuedependent genetic variation of gene expression. PLoS Genet 2012, 8:e1002431.
12. Lister R, Pelizzola M, Dowen RH, Hawkins RD, Hon G, Tonti-Filippini J, Nery JR, Lee L, Ye Z, Ngo Q-M, Edsall L, Antosiewicz-Bourget J, Stewart R, Ruotti V, Millar AH, Thomson JA, Ren B, Ecker JR: Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 2009, 462:315-322.
13. Ghosh S, Yates AJ, Frühwald MC, Miecznikowski JC, Plass C, Smiraglia D: Tissue specific DNA methylation of CpG islands in normal human adult somatic tissues distinguishes neural from non-neural tissues. Epigenetics 2010, 5:527-538.
14. Varley KE, Gertz J, Bowling KM, Parker SL, Reddy TE, Pauli-Behn F, Cross MK, Williams BA, Stamatoyannopoulos JA, Crawford GE, Absher DM, Wold BJ, Myers RM: Dynamic DNA methylation across diverse human cell lines and tissues. Genome Res 2013, 23:555-567.
15. Ghotbi R, Gomez A, Milani L, Tybring G, Syvänen AC, Bertilsson L, Ingelman-Sundberg M, Aklillu E: Allele-specific expression and gene methylation in the control of CYP1A2 mRNA level in human livers. Pharmacogenomics J 2009, 9:208-217.
16. Thomson JP, Hunter JM, Lempiäinen H, Müller A, Terranova R, Moggs JG, Meehan RR: Dynamic changes in 5-hydroxymethylation signatures underpin early and late events in drug exposed liver. Nucleic Acids Res 2013, 41:5639-5654.
17. Chen WD, Fu X, Dong B, Wang YD, Shiah S, Moore DD, Huang W: Neonatal activation of the nuclear receptor CAR results in epigenetic memory and permanent change of drug metabolism in mouse liver. Hepatology 2012, 56:1499-1509.
18. Kacevska M, Ivanov M, Ingelman-Sundberg M: Epigenetic-dependent regulation of drug transport and metabolism: An update. Pharmacogenomics 2012, 13:1373-1385.
19. McLean CY, Bristor D, Hiller M, Clarke SL, Schaar BT, Lowe CB, Wenger AM, Bejerano G: GREAT improves functional interpretation of cis-regulatory regions. Nat Biotechnol 2010, 28:495-501.
20. Cvejic A, Haer-Wigman L, Stephens JC, Kostadima M, Smethurst PA, Frontini M, van den Akker E, Bertone P, Bielczyk-Maczyńska E, Farrow S, Fehrmann RSN, Gray A, de Haas M, Haver VG, Jordan G, Karjalainen J, Kerstens HHD, Kiddle G, Lloyd-Jones H, Needs M, Poole J, Soussan AA, Rendon A, Rieneck K, Sambrook JG, Schepers H, Silljé HHW, Sipos B, Swinkels D, Tamuri AU: SMIM1 underlies the Vel blood group and influences red blood cell traits. Nat Genet 2013, 45:542-545.
21. Moscovitz JE, Aleksunes LM: Establishment of metabolism and transport pathways in the rodent and human fetal liver. Int J Mol Sci 2013, 14:23801-23827.
22. Yang X, Zhang B, Molony C, Chudin E, Hao K, Zhu J, Gaedigk A, Suver C, Zhong H, Leeder JS, Guengerich FP, Strom SC, Schuetz E, Rushmore TH, Ulrich RG, Slatter JG, Schadt EE, Kasarskis A, Lum PY: Systematic genetic and genomic analysis of cytochrome P450 enzyme activities in human liver. Genome Res 2010, 20:1020-1036.
23. Lee JS, Ward WO, Knapp G, Ren H, Vallanat B, Abbott B, Ho K, Karp SJ, Corton JC: Transcriptional ontogeny of the developing liver. BMC Genomics 2012, 13:33.
24. Jochheim-Richter A, Rüdrich U, Koczan D, Hillemann T, Tewes S, Petry M, Kispert A, Sharma AD, Attaran F, Manns MP, Ott M: Gene expression analysis identifies novel genes participating in early murine liver development and adult liver regeneration. Differentiation 2006, 74:167-173.
25. Li T, Huang J, Jiang Y, Zeng Y, He F, Zhang MQ, Han Z, Zhang X: Multistage analysis of gene expression and transcription regulation in C57/B6 mouse liver development. Genomics 2009, 93:235-242.
26. Gutierrez-Arcelus M, Lappalainen T, Montgomery SB, Buil A, Ongen H, Yurovsky A, Bryois J, Giger T, Romano L, Planchon A, Falconnet E, Bielser D, Gagnebin M, Padioleau I, Borel C, Letourneau A, Makrythanasis P, Guipponi M, Gehrig C, Antonarakis SE, Dermitzakis ET: Passive and active DNA methylation and the interplay with genetic variation in gene regulation. Elife 2013, 2:e00523.
27. Bell JT, Spector TD: DNA methylation studies using twins: what are they telling us? Genome Biol 2012, 13:172.
28. Jones PA: Functions of DNA methylation: Islands, start sites, gene bodies and beyond. Nat Rev Genet 2012, 13:484-492.
29. Wolf SF, Jolly DJ, Lunnen KD, Friedmann T, Migeon BR: Methylation of the hypoxanthine phosphoribosyltransferase locus on the human X chromosome: Implications for X-chromosome inactivation. Proc Natl Acad Sci U S A 1984, 81:2806-2810.
30. Jones PA: The DNA methylation paradox. Trends Genet 1999, 15:34-37.
31. Ingelman-Sundberg M, Sim SC, Gomez A, Rodriguez-Antona C: Influence of cytochrome P450 polymorphisms on drug therapies: Pharmacogenetic, pharmacoepigenetic and clinical aspects. Pharmacol Ther 2007, 116:496-526.
32. Marinković N, Pasalić D, Potocki S: Polymorphisms of genes involved in polycyclic aromatic hydrocarbons' biotransformation and atherosclerosis. Biochem Med (Zagreb) 2013, 23:255-265.
33. Tulsyan S, Chaturvedi P, Agarwal G, Lal P, Agrawal S, Mittal RD, Mittal B: Pharmacogenetic influence of GST polymorphisms on anthracyclinebased chemotherapy responses and toxicity in breast cancer patients: A multi-analytical approach. Mol Diagn Ther 2013, 17:371-379.
34. Ramos DL, Gaspar JF, Pingarilho M, Gil OM, Fernandes AS, Rueff J, Oliveira NG: Genotoxic effects of doxorubicin in cultured human lymphocytes with different glutathione S-transferase genotypes. Mutat Res 2011, 724:28-34.
35. Zhong S, Huang M, Yang X, Liang L, Wang Y, Romkes M, Duan W, Chan E, Zhou SF: Relationship of glutathione S-transferase genotypes with sideeffects of pulsed cyclophosphamide therapy in patients with systemic lupus erythematosus. Br J Clin Pharmacol 2006, 62:457-472.
36. Liu Y, Ding J, Reynolds LM, Lohman K, Register TC, De La Fuente A, Howard TD, Hawkins GA, Cui W, Morris J, Smith SG, Barr RG, Kaufman JD, Burke GL, Post W, Shea S, McCall CE, Siscovick D, Jacobs DR, Tracy RP, Herrington DM, Hoeschele I: Methylomics of gene expression in human monocytes. Hum Mol Genet 2013, 22:5065-5074.
37. Sintupisut N, Liu PL, Yeang CH: An integrative characterization of recurrent molecular aberrations in glioblastoma genomes. Nucleic Acids Res 2013, 41:8803-8821.
38. Chambers JC, Zhang W, Sehmi J, Li X, Wass MN, Van der Harst P, Holm H, Sanna S, Kavousi M, Baumeister SE, Coin LJ, Deng G, Gieger C, Heard-Costa NL, Hottenga J-J, Kühnel B, Kumar V, Lagou V, Liang L, Luan J, Vidal PM, Mateo Leach I, O'Reilly PF, Peden JF, Rahmioglu N, Soininen P, Speliotes EK, Yuan X, Thorleifsson G, Alizadeh BZ: Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma. Nat Genet 2011, 43:1131-1138.
39. Fuhrman B: Regulation of hepatic paraoxonase-1 expression. J Lipids 2012, 2012:684010.
40. Liu ME, Liao YC, Lin RT, Wang YS, Hsi E, Lin HF, Chen KC, Juo SH: A functional polymorphism of PON1 interferes with microRNA binding to increase the risk of ischemic stroke and carotid atherosclerosis. Atherosclerosis 2013, 228:161-167.
41. Deakin S, Leviev I, Brulhart-Meynet MC, James RW: Paraoxonase-1 promoter haplotypes and serum paraoxonase: A predominant role for polymorphic position - 107, implicating the Sp1 transcription factor. Biochem J 2003, 372:643-649.
42. Brophy VH, Hastings MD, Clendenning JB, Richter RJ, Jarvik GP, Furlong CE: Polymorphisms in the human paraoxonase (PON1) promoter. Pharmacogenetics 2001, 11:77-84.
43. Miyamoto Y, Koh YH, Park YS, Fujiwara N, Sakiyama H, Misonou Y, Ookawara T, Suzuki K, Honke K, Taniguchi N: Oxidative stress caused by inactivation of glutathione peroxidase and adaptive responses. Biol Chem 2003, 384:567-574.
44. Yang P, Ebbert JO, Sun Z, Weinshilboum RM: Role of the glutathione metabolic pathway in lung cancer treatment and prognosis: A review. J Clin Oncol 2006, 24:1761-1769.
45. Peng D, Hu T, Soutto M, Belkhiri A, Zaika A, El-Rifai W: Glutathione peroxidase 7 has potential tumour suppressor functions that are silenced by location-specific methylation in oesophageal adenocarcinoma. Gut 2014, 63:540-551.
46. Kacevska M, Ivanov M, Wyss A, Kasela S, Milani L, Rane A, Ingelman-Sundberg M: DNA methylation dynamics in the hepatic CYP3A4 gene promoter. Biochimie 2012, 94:2338-2344.
47. Ivanov M, Kals M, Kacevska M, Barragan I, Kasuga K, Rane A, Metspalu A, Milani L, Ingelman-Sundberg M: Ontogeny, distribution and potential roles of 5-hydroxymethylcytosine in human liver function. Genome Biol 2013, 14:R83.
48. Wolfs MGM, Rensen SS, Bruin-Van Dijk EJ, Verdam FJ, Greve J-W, Sanjabi B, Bruinenberg M, Wijmenga C, van Haeften TW, Buurman WA, Franke L, Hofker MH: Co-expressed immune and metabolic genes in visceral and subcutaneous adipose tissue from severely obese individuals are associated with plasma HDL and glucose levels: A microarray study. BMC Med Genomics 2010, 3:34.